References
- Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study of Osteoporotic Fractures Research Group. Lancet. 1999;354(9183):971–975.
- Shimizu H, Nakagami H, Yasumasa N, Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel. Hyperten Res. 2012;35(1):77–81.
- Awad AB, Alappat L, Valerio M. Vitamin D and metabolic syndrome risk factors: evidence and mechanisms. Crit Rev Food Sci Nutr. 2012;52(2):103–112.
- Unlu M, Karaman M, Ay SA, et al. The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients. Clin Exp Hypertens. 2012. [Epub ahead of print]. doi: 10.3109/10641963. 2012.739237.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
- Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hyperten. 2006;24(3):581–589.
- Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int. 2005;76(3):167–175.
- McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med. 2011;155(12):820–826.
- Kota SK, Kota SK, Jammula S, Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: an urban Indian study. Indian J Endocrinol Metab. 2011;15(Suppl. 4):S395–S401.
- McCarron DA. Blood pressure and calcium balance in the Wistar-Kyoto rat. Life Sci. 1982;30(7–8):683–689.
- Young EW, Bukoski RD, McCarron DA. Calcium metabolism in experimental hypertension. Proc Soc Exp Biol Med. 1988;187(2):123–141.
- Fukuda S, Tsuchikura S, Iida H, Ikeda K, Nara Y, Yamori Y. Intestinal calcium absorption and response of calcium regulating hormones in the stroke-prone spontaneously hypertensive rat as a model of osteoporosis. Clin Exp Pharmacol Physiol Suppl. 1995;22(1):S240–S241.
- Yamori Y, Fukuda S, Tsuchikura S, Ikeda K, Nara Y, Horie R. Stroke-prone SHR (SHRSP) as a model for osteoporosis. Clin Exp Hyperten Part A. 1991;13(5):755–762.
- Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens. 2001;14(7 Pt 1):704–707.
- Ushijima K, Liu Y, Maekawa T, Protective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol. 2010;635(1–3):227–230.
- Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int. 2009;84(2):103–111.
- Zicha J, Kunes J, Ben-Ishay D, Devynck MA. Abnormal regulation of cytosolic calcium and pH in platelets of Sabra rats in early phases of salt hypertension development. Can J Physiol Pharmacol. 1996;74(11):1222–1228.
- Kanbay M, Isik B, Akcay A, Relation between serum calcium, phosphate, parathyroid hormone and “nondipper” circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 2007;27(5):516–521.
- Halici Z, Borekci B, Ozdemir Y, Cadirci E, Suleyman H. Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats. Eur J Pharmacol. 2008;579(1–3):241–245.
- Gradosova I, Zivna H, Palicka V, Hubena S, Svejkovska K, Zivny P. Protective effect of amlodipine on rat bone tissue after orchidectomy. Pharmacology. 2012;89(1–2):37–43.
- Moraes RB, Corrêa L, Luz JGC. Adverse effects of the amlodipine on bone healing of the mandibular fracture: an experimental study in rats. Oral Maxillofac Surg. 2011;15(2):93–101.